Current status of authorisations for combating COVID-19

Status as at 30 April 2024 – This page is no longer being updated. You can find the Information for healthcare professionals and Patient information for authorised medicinal products here.

Applications received by Swissmedic for the authorisation (or authorisation extension in the case of vaccines) for COVID-19 vaccines and therapeutic agents against COVID-19 and the current status of the authorisation procedures.


Authorisation procedures for vaccines against COVID-19



Authorisation procedures for therapeutic agents against COVID-19


Review begins as soon as the formal check on the documents submitted is complete. The check lasts from a few hours up to a few days.
“Under (rolling) review” denotes that Swissmedic is examining the data submitted with regard to safety, efficacy and quality, is clarifying open issues with the companies and/or is demanding additional results
3Only the first authorisation in the context of COVID-19 is listed; for the sake of clarity, no indication extensions are shown
4Conversion to ordinary authorisation applied for, in respect of vaccine for which temporary authorisation had been issued.
5Temporary authorisation extended by Swissmedic (until official decision published, but not beyond 13.09.2023).
6Temporary authorisation extended by Swissmedic (until official decision published, but not beyond 15.01.2024).
7 Assessment as part of a simple update procedure